Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas-Reference-Cited by-同舟云学术

Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas

Published:2006-02 Issue:2 Volume:100 Page:264-270
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Brown Lindsay A.,Irving Julie,Parker Robin,Kim Hanna,Press Joshua Z.,Longacre Teri A.,Chia Stephen,Magliocco Anthony,Makretsov Nikita,Gilks Blake,Pollack Jonathan,Huntsman David

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference33 articles.

1. Chromosome 11q13 markers and D-type cyclins in breast cancer;Peters;Breast Cancer Res. Treat.,1995

2. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer;Karlseder;Genes Chromosomes Cancer,1994

3. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer;Hui;Oncogene,1997

4. Detailed map of a region commonly amplified at 11q13 → q14 in human breast carcinoma;Bekri;Cytogenet. Cell Genet.,1997

5. Cyclin D1, EMS1 and 11q13 amplification in breast cancer;Ormandy;Breast Cancer Res. Treat.,2003

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Classification and Histopathological Diagnosis of Ovarian Epithelial Malignant Tumours;Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer;2023-01-18

2. Clinicopathological Significances and Prognostic Value of PPFIA4 in Colorectal Cancer;Journal of Cancer;2023

3. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma;Combinatorial Chemistry & High Throughput Screening;2022-10

4. The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma;Cell Death & Disease;2021-12-20

5. Homologous recombination proficiency in ovarian and breast cancer patients;BMC Cancer;2021-10-28